News
Many patients with adrenal insufficiency or their caregivers cannot administer emergency glucocorticoid injections, resulting ...
Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...
Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...
A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...
Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...
2d
Study Finds on MSN250+ Scientists Are Building The Most Complex Map Of Human Genetic Mutations Ever CreatedScientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...
3d
Bangkok Post on MSNScreening a deadly diseaseWhen celebrated actor, Natthawut "Poh" Skidjai, revealed on his YouTube channel @PohSakidAey that his wife Aey Pornthip had ...
Stress doesn’t just affect your mind, it disrupts your gut too, triggering bloating, inflammation, and digestive issues through the gut-brain connection.
Hypertension affects one in three adults globally and is the leading modifiable risk factor for cardiovascular disease.
SYDNEY, June 30, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the 100 th participant in its pivotal XanaMIA phase 2b /3 randomized trial of Xanamem ® for Alzheimer's ...
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant enrolled in the XanaMIA trial, the timeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results